Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

ChanRx is Profiled in this Database

Updated At 31 May, 2012

Start Free 7 Day Trial Now
Partial description of this company
Small molecule drug candidates directed at ion channel targets to repurpose existing therapies for atrial fibrillation

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of ChanRx plus 4970 other startups.

Start Free 7 Day Trial Now

Learn More About ChanRx

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

More

Our Clients